Staff Reports
The Trump administration is shining a light on the alarming rise in autism rates that American families have faced for decades. Under President Trump’s leadership, the government is no longer sidestepping the issue or letting pharmaceutical giants and political correctness dictate public health policy. Instead, there’s a determined push for answers and accountability that many believe should have come long ago.
For years, autism was a rare diagnosis, but today, millions of families struggle to find resources and support for their children. The spike in cases has been met with silence and evasion from the Left and their media allies, who tend to blame genetics or other “safe” explanations while ignoring anything that might upset their donors or ideological narrative. President Trump’s approach is a welcome change—he refuses to let corporate interests or political sensitivities get in the way of investigating possible environmental and pharmaceutical causes.
🚨 BREAKING: Secretary Robert F. Kennedy Jr. announces "folate deficiency in a child's brain can lead to autism."
And an "exciting therapy" for kids with autism: leucovorin. Up to 60% of deficient children can have improved communication if they take it.
GREAT NEWS. This is… pic.twitter.com/MAEdSK7YlB
— Eric Daugherty (@EricLDaugh) September 22, 2025
This administration, with allies like Robert F. Kennedy Jr., is asking the tough questions most politicians avoid. Emerging research on medications such as acetaminophen, commonly found in Tylenol, is prompting recommendations that expectant mothers steer clear to better protect their babies. Trump has also urged a reexamination of the vaccine schedule for newborns—a move that prioritizes parental choice over industry profits. These efforts signal genuine concern for Americans rather than rote adherence to a “standard” set by Big Pharma and pushed by liberal policymakers.
New findings are prompting real change, with increased scrutiny on how simple solutions like folate supplementation may aid children with autism. Instead of burying uncomfortable data, Trump’s team is giving scientists and health professionals the freedom to explore answers that actually matter for families. The willingness to investigate and act, even if politically unpopular, sets this leadership apart from predecessors who let fear and globalist interests squash real inquiry.
As the mainstream media continues to dismiss or downplay alternative perspectives, many are left wondering whose interests they truly serve. President Trump’s direct approach is putting American families first—calling for transparency, fighting for accountability, and refusing to let failed policies from the Left stand in the way of progress. This kind of leadership is not just refreshing; it’s necessary in the battle for our children’s futures.
